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E.coli can cause severe respiratory and sistemic infections in chickens, responsible for 
significant economic losses in the poultry industry. Phages are good candidates to treat 
bacterial infections as alternative to antibiotics. In order to predict the efficacy of phage therapy, 
it is important to know the phage(s) dissemination in the animal body. In vivo trials were 
conducted by infecting chickens with three lytic phages: F78E (Myoviridae), F258E 
(Syphoviridae) and F61E (Myoviridae). 106, 107 and 108pfu were administered in the drinking 
water, by spray and intramuscularly. Birds were euthanised after 3, 10 and 24h of phage 
challenge and pfu were measured from the supernatants of emulsified lungs and air sac 
membranes, liver, duodenum and spleen. The three routes of administration, oral, spray and 
intramuscular, were found to be effective in delivering the phages to the respiratory tract, which 
is an important target organ for E. coli infections. When administration was by spray all the 3 
phages reached the respiratory tract 3h after challenge, despite the different phage amounts 
recovered. When the routes of administration were oral or spray, phages F258 and F61E were 
never found in the animal’s duodenums, conversely phage F78E was found in their intestinal 
content. The presence of phage F78E in the duodenum was probably due to the existence of a 
commensally enteric host, sensitive to this phage. As this phage was also found in spleens and 
livers, it has probably crossed the intestinal mucosa. The results suggest that the presence of 
commensal host strains can increase the efficacy of phage therapy. It was possible to conclude 
that, to treat respiratory E.coli infections in poultry industry, spray and drinking water are 
promissing administration ways.  
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